5. Conclusion
The mortality rate was reported 4% and 32% in the intervention and control groups, respectively. Moreover, the mean hospitalization days were 7.02 vs. 10.83 in the PTX and control group, respectively. Therefore, pentoxifylline increased the survival rate of hospitalized COVID-19 patients and played a preventive role for COVID-related mortality and morbidity such as ARDS.